RedShiftBio's AQS3pro featuring MMS addresses deficiencies in today’s analytical techniques that hamper biopharmaceutical scientists in their mission to bring to market safer, more stable treatments for disease. The system, combined with a powerful analytics package - AQS3delta, is a high performance fully automated system allowing you to quickly and easily run samples, process data and gain insight.

Change How You See Proteins

Proteins are a large and highly variable group of biological molecules. Their structural complexity means the development and commercialization of the final biologic is a challenging process; The AQS3pro delivers the increased analytics capabilities to accurately characterize and quantitate them though out the biotheraputic development process.

The AQS3pro featuring Microfluidic Modulation Spectroscopy, or MMS technology, empowers biopharmaceutical scientists by combining the high energy of a laser with microfluidic flow technologies to see change in the proteins’ secondary structure. The instrument measures the amide I band spectral absorbance of proteins in solution to provide increased confidence in data and decreased resources by enabling:

Visit our growing resource library of application notes, posters and whitepapers.


RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Read More



Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301

RedShift™, RedShiftBio™,  See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.